Učitavanje...

Remodeling of the HDL Proteome with Treatment Response to Abatacept or Adalimumab in the AMPLE Trial of Patients with Rheumatoid Arthritis

BACKGROUND AND AIMS: To evaluate changes in the high-density lipoprotein (HDL) proteome and HDL function in active RA patients initiating therapy with abatacept or adalimumab in the Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Subjects with Background Methotrexate (AMPLE) study. METHO...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Atherosclerosis
Glavni autori: Charles-Schoeman, C, Gugiu, GB, Ge, H, Shahbazian, A, Lee, YY, Wang, X, Furst, DE, Ranganath, VK, Maldonado, M, Lee, Terry, Reddy, ST
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113060/
https://ncbi.nlm.nih.gov/pubmed/29886354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2018.04.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!